Volume 68, Issue 4, Pages (October 2005)

Slides:



Advertisements
Similar presentations
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Advertisements

Volume 66, Issue 1, Pages (July 2004)
Volume 63, Issue 6, Pages (June 2003)
Volume 64, Issue 6, Pages (December 2003)
Volume 66, Issue 6, Pages (December 2004)
Volume 66, Issue 4, Pages (October 2004)
Volume 58, Issue 4, Pages (October 2000)
Volume 69, Issue 6, Pages (March 2006)
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Angiogenesis in autosomal-dominant polycystic kidney disease
Volume 63, Issue 2, Pages (February 2003)
Volume 73, Issue 3, Pages (February 2008)
Volume 71, Issue 3, Pages (February 2007)
Volume 56, Issue 6, Pages (December 1999)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 78, Issue 8, Pages (October 2010)
Volume 69, Issue 11, Pages (June 2006)
Volume 64, Issue 1, Pages (July 2003)
Volume 83, Issue 5, Pages (May 2013)
Volume 66, Issue 6, Pages (December 2004)
Volume 61, Issue 5, Pages (May 2002)
Volume 58, Issue 6, Pages (December 2000)
Kidney involvement in a nongenetic rat model of type 2 diabetes
Volume 63, Issue 6, Pages (June 2003)
Volume 59, Issue 5, Pages (May 2001)
Volume 87, Issue 2, Pages (February 2015)
Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding  Kidney International 
Endothelial-derived vasoactive mediators in polycystic kidney disease
Volume 63, Issue 5, Pages (May 2003)
Volume 85, Issue 5, Pages (May 2014)
Prenatal programming of adult hypertension in the rat
Volume 60, Issue 5, Pages (November 2001)
Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 79, Issue 9, Pages (May 2011)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 63, Issue 2, Pages (February 2003)
Volume 77, Issue 4, Pages (February 2010)
Volume 72, Issue 4, Pages (August 2007)
Volume 75, Issue 2, Pages (January 2009)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 79, Issue 4, Pages (February 2011)
Volume 65, Issue 1, Pages (January 2004)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 61, Issue 6, Pages (June 2002)
Volume 62, Issue 3, Pages (September 2002)
Volume 65, Issue 2, Pages (February 2004)
Volume 68, Issue 6, Pages (December 2005)
Volume 58, Issue 6, Pages (December 2000)
Volume 70, Issue 10, Pages (November 2006)
Volume 66, Issue 1, Pages (July 2004)
Volume 74, Issue 6, Pages (September 2008)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Volume 62, Issue 3, Pages (September 2002)
Volume 65, Issue 6, Pages (June 2004)
Volume 66, Issue 3, Pages (September 2004)
Volume 60, Issue 1, Pages (July 2001)
Volume 60, Issue 5, Pages (November 2001)
Endothelin antagonists in renal disease
The course of the remnant kidney model in mice
Increased importin α protein expression in diabetic nephropathy
Volume 87, Issue 3, Pages (March 2015)
Volume 58, Issue 3, Pages (September 2000)
Volume 62, Issue 5, (November 2002)
Volume 72, Issue 11, Pages (December 2007)
Volume 61, Issue 1, Pages (January 2002)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 75, Issue 5, Pages (March 2009)
Presentation transcript:

Volume 68, Issue 4, Pages 1729-1739 (October 2005) Gender hormones and the progression of experimental polycystic kidney disease  Kenneth D. Stringer, Radko Komers, Shukri A. Osman, Terry T. Oyama, Jessie N. Lindsley, Sharon Anderson  Kidney International  Volume 68, Issue 4, Pages 1729-1739 (October 2005) DOI: 10.1111/j.1523-1755.2005.00589.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Body weights in male and female control and cystic rats, with or without gonadectomy [orchiectomy (Orch) or ovariectomy (OVX)]. Males were heavier than females at both time points (P < 0.01). Body weights increased in all groups (P < 0.01 vs. 6 weeks of age). The cystic phenotype did not affect body weight. Orchiectomy had no effect on body weight in male rats, but ovariectomy significantly increased body weight gain in female rats (P < 0.01 vs. other female groups). * P < 0.01 vs. other female groups. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Systolic blood pressures (SBP) in male and female control and cystic rats, with or without gonadectomy. Values for systolic blood pressure were similar in all groups at 6 weeks of age, except slightly higher in cystic than control males (P < 0.05). By 12 weeks of age, systolic blood pressure was numerically but not statistically higher in both male and female cystic rats, and systolic blood pressure rose significantly in cystic ovariectomy females (P < 0.01). *P < 0.05 vs. control males; †P < 0.05, Cys/ovariectomy, 12 weeks of age vs. baseline. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Urinary protein excretion (UprotV) in male and female control and cystic (Cys) rats, with or without gonadectomy [orchiectomy (Orch) and ovariectomy (OVX)]. Values for UprotV were low in all groups at 6 weeks of age, and significantly lower in females than in the corresponding males (P < 0.05). By 12 weeks of age, UprotV had increased significantly in male control (P < 0.05) and cystic (P < 0.005) rats, and orchiectomy did not attenuate the rise in proteinuria. Values in all female groups remained comparable, and lower than those in the male groups (P < 0.05). *P < 0.01 vs. baseline; †P < 0.05 vs. control males. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Representative photomicrographs of renal cortex and medulla in male and female, cystic and noncystic rats. Cystic changes were apparent in both compartments in male rats, but were less prominent in female rats [40× periodic acid-Schiff (PAS) stain]. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Plasma renin concentration (PRC), renal renin concentration (RRC), and renal endothelin-1 (ET-1). PRC and RRC were suppressed in the cystic male groups, but not in the cystic female groups. Renal ET-1 expression was up-regulated in cystic males, and not affected by orchiectomy. In females, the degree of up-regulation associated with the cystic state was lesser than in males, and was attenuated by ovariectomy. *P < 0.01 vs. respective control; †P < 0.05 vs. respective male group. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Representative Western blots of vascular endothelial growth factor (VEGF) and actin in male and female, cystic and noncystic rats. (A) The VEGF/actin ratio was reduced in male cystic (MCys) rats, as compared with noncystic controls (MC). Noncystic females (FC) demonstrated higher expression than noncystic males, but the cystic phenotype (FCys) was also associated with reduction in VEGF expression in female rats. *P < 0.05 vs. control males; †P < 0.01 vs. control females. (B) Orchiectomy (Orch) led to a slight but not significant increase in VEGF; ovariectomy (OVX) significantly reduced renal VEGF expression. *P < 0.05 vs. respective controls; †P < 0.01 vs. cystic females. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Representative immunohistochemical expression of vascular endothelial growth factor (VEGF) in male and female, cystic and noncystic rats. Left panels show sections stained with anti-VEGF antibody. Right panels show parallel control sections incubated with nonimmune serum. In noncystic male and female kidneys, the VEGF was found predominantly in distal tubules (green arrows), glomerular epithelial cells (black arrows), and in some arterial or arteriolar endothelia (red arrows). In both male and female cystic rats, renal VEGF immunoreactivity was found mainly in epithelial cells lining the cyst walls as well in atrophic tubuli (blue arrows). There were no apparent differences between male and female rats. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Representative Western blots of endothelial nitric oxide synthase (eNOS) and actin in male (A) and female (B), cystic and noncystic rats. (C) The eNOS/actin ratio was increased in male cystic rats, as compared with noncystic controls, and not affected by orchiectomy (Orch). In females, the cystic state was associated with further up-regulation of eNOS, but this up-regulation was limited by ovariectomy (OVX). MW is molecular weight standard; L is human endothelial cell lysate positive control. *P < 0.001 vs. respective noncystic controls; †P < 0.01 vs. cystic females. Kidney International 2005 68, 1729-1739DOI: (10.1111/j.1523-1755.2005.00589.x) Copyright © 2005 International Society of Nephrology Terms and Conditions